A Phase 1, Open Label, Single Center, Randomized, Six-Sequence, Crossover Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects
Latest Information Update: 17 Jan 2017
At a glance
- Drugs Mongersen (Primary) ; Omeprazole
- Indications Crohn's disease; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Celgene Corporation
- 11 Jan 2017 Status changed from not yet recruiting to completed.
- 11 Nov 2016 New trial record